Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting
Benjamin Goldenson, Pooja Hor, Dan S. Kaufman
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances
Karama Makni‐Maalej, Maysaloun Merhi, Varghese Inchakalody, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 289
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Qiaofei Liu, Jiayi Li, Huaijin Zheng, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 67
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 67
CAR-NK cells for cancer immunotherapy: recent advances and future directions
Tianye Li, Mengke Niu, Weijiang Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 24
New cell sources for CAR-based immunotherapy
Marzieh Mazinani, Fatemeh Rahbarizadeh
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 25
Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells
Fanyi Meng, Siqi Zhang, Juan Xie, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 25
Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy
Andreia Maia, Mubin Tarannum, Joana R. Lérias, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 451-451
Open Access | Times Cited: 15
Biomaterials to enhance adoptive cell therapy
Noah Eckman, Anahita Nejatfard, Romola Cavet, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 5, pp. 408-424
Closed Access | Times Cited: 14
synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy
Kyle B. Lupo, Xue Yao, Shambhavi Borde, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Disruption of TGF-β signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells
Jaya Lakshmi Thangaraj, Michael Coffey, Edith Lopez, et al.
Cell stem cell (2024) Vol. 31, Iss. 9, pp. 1327-1343.e5
Closed Access | Times Cited: 14
Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors
Tobias Bexte, Lacramioara Botezatu, Csaba Miskey, et al.
Molecular Therapy (2024) Vol. 32, Iss. 7, pp. 2357-2372
Closed Access | Times Cited: 12
Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies
Christina Angeliki Tsiverioti, Adrian Gottschlich, Marcel P. Trefny, et al.
Biological Chemistry (2024) Vol. 405, Iss. 7-8, pp. 485-515
Open Access | Times Cited: 8
Innate Immune Cells in Tumour Microenvironment: A New Frontier in Cancer Immunotherapy
Changhui Li, Xinyu Yu, Xinyan Han, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110750-110750
Open Access | Times Cited: 8
Engaging stemness improves cancer immunotherapy
Hassan Dianat‐Moghadam, Mohammadreza Sharifi, Rasoul Salehi, et al.
Cancer Letters (2022) Vol. 554, pp. 216007-216007
Closed Access | Times Cited: 37
Current Progress of CAR-NK Therapy in Cancer Treatment
Zhaojun Pang, Zhongyi Wang, Fengqi Li, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4318-4318
Open Access | Times Cited: 34
CAR-NK cell therapy for glioblastoma: what to do next?
Qi Xiong, Jiao Zhu, Yong Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 18
Empowering pancreatic tumor homing with augmented anti-tumor potency of CXCR2-tethered CAR-NK cells
Jong Hyeon Yoon, Han‐Na Yoon, Hyun Ju Kang, et al.
Deleted Journal (2024) Vol. 32, Iss. 1, pp. 200777-200777
Open Access | Times Cited: 6
A new vision of the efficacy of both CAR-NK and CAR-T cells in treating cancers and autoimmune diseases
Salim Hussein Hassan, Mohammad Y. Alshahrani, Raed Obaid Saleh, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access | Times Cited: 6
Natural killer cells in cancer immunotherapy
Danru Wang, LingYun Dou, Lihao Sui, et al.
MedComm (2024) Vol. 5, Iss. 7
Open Access | Times Cited: 6
Role of CD19 Chimeric Antigen Receptor T Cells in Second-Line Large B Cell Lymphoma: Lessons from Phase 3 Trials. An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy
Miguel-Ángel Perales, Larry D. Anderson, Tania Jain, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 9, pp. 546-559
Open Access | Times Cited: 27
NK Cell-Based Immunotherapy in Colorectal Cancer
Mariella Della Chiesa, Chiara Setti, Chiara Giordano, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1033-1033
Open Access | Times Cited: 26
CAR-NK as a Rapidly Developed and Efficient Immunotherapeutic Strategy against Cancer
Marta Włodarczyk, Beata Pyrzyńska
Cancers (2022) Vol. 15, Iss. 1, pp. 117-117
Open Access | Times Cited: 25
CAR NK Cells: The Future Is Now
Martin Raftery, Alexander Sebastian Franzén, Gabriele Pecher
Annual Review of Cancer Biology (2023) Vol. 7, Iss. 1, pp. 229-246
Open Access | Times Cited: 14
DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy
Loredana Cifaldi, Ombretta Melaiu, Roberto Giovannoni, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Genetic Manipulation Approaches to Enhance the Clinical Application of NK Cell-Based Immunotherapy
Andreia Maia, Mubin Tarannum, Rizwan Romee
Stem Cells Translational Medicine (2023) Vol. 13, Iss. 3, pp. 230-242
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top